ArticleNature2018
Ma et al. reply.
Abstract read
In one paragraph
Article in Nature, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Asymmetric attrition and secondary chromosome destabilization after double-strand breaks in human embryonic development.Nature communications · 2026Article
- Retained chromosomal integrity following CRISPR-Cas9-based mutational correction in human embryos.Molecular therapy : the journal of the American Society of Gene Therapy · 2023Article
- Limitations of gene editing assessments in human preimplantation embryos.Nature communications · 2023Article
- Association of endometriosis with cardiovascular disease: Genetic aspects (Review).International journal of molecular medicine · 2023Review
- Site-specific genome editing in treatment of inherited diseases: possibility, progress, and perspectives.Medical review (2021) · 2022Review
- Active genetics comes alive: Exploring the broad applications of CRISPR-based selfish genetic elements (or gene-drives): Exploring the broad applications of CRISPR-based selfish genetic elements (or gene-drives).BioEssays : news and reviews in molecular, cellular and developmental biology · 2022Review
- Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing.Protein & cell · 2022Review
- CRISPR-based genome editing through the lens of DNA repair.Molecular cell · 2022Review
- Article
- Reviewing the role of gut microbiota in the pathogenesis of depression and exploring new therapeutic options.Frontiers in neuroscience · 2022Review
- Frequent loss of heterozygosity in CRISPR-Cas9-edited early human embryos.Proceedings of the National Academy of Sciences of the United States of America · 2021Article
- Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.Molecular therapy : the journal of the American Society of Gene Therapy · 2020Review
- On-Target CRISPR/Cas9 Activity Can Cause Undesigned Large Deletion in Mouse Zygotes.International journal of molecular sciences · 2020Article
- Human germline genome editing.Nature cell biology · 2019Review
- The technical risks of human gene editing.Human reproduction (Oxford, England) · 2019Article
- Human germline editing: Insights to future clinical treatment of diseases.Protein & cell · 2019Review
- Principles of and strategies for germline gene therapy.Nature medicine · 2019Review
- The CRIPSR/Cas gene-editing system-an immature but useful toolkit for experimental and clinical medicine.Animal models and experimental medicine · 2019Article
- Off- and on-target effects of genome editing in mouse embryos.The Journal of reproduction and development · 2019Article
- Fearful old world? A commentary on the Second International Summit on human genome editing.Mammalian genome : official journal of the International Mammalian Genome Society · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
32 authors.
Hong MaCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Nuria Marti-GutierrezCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Sang-Wook ParkCenter for Genome Engineering, Institute for Basic Science, Daejeon, South Korea.
Jun WuGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.
Tomonari HayamaCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Hayley DarbyCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Crystal Van DykenCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Ying LiCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Amy KoskiCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Dan LiangCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Keiichiro SuzukiGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.
Ying GuBGI-Shenzhen, Beishan Industrial Zone, Shenzhen, China.
Jianhui GongBGI-Shenzhen, Beishan Industrial Zone, Shenzhen, China.
Xun XuBGI-Shenzhen, Beishan Industrial Zone, Shenzhen, China.
Riffat AhmedCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Yeonmi LeeCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Eunju KangCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Dongmei JiCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
A-Reum ParkCenter for Genome Engineering, Institute for Basic Science, Daejeon, South Korea.
Daesik KimDepartment of Chemistry, Seoul National University, Seoul, South Korea.
Sang-Tae KimCenter for Genome Engineering, Institute for Basic Science, Daejeon, South Korea.
Stephen B HeitnerKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
David BattagliaCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Sacha A KriegDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
David M LeeDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Diana H WuDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA.
Don P WolfCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Paula AmatoCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA.
Sanjiv KaulKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Juan Carlos Izpisua BelmonteGene Expression Laboratory, Salk Institute for Biological Studies, La Jolla, CA, USA.
Jin-Soo KimCenter for Genome Engineering, Institute for Basic Science, Daejeon, South Korea.
Shoukhrat MitalipovCenter for Embryonic Cell and Gene Therapy, Oregon Health & Science University, Portland, OR, USA. mitalipo@ohsu.edu.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
30089923What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.